Novavax Inc (NVAX)

Industry Biotechnology


This stock can be held in an Investment ISA and an Investment Account
Sell

$7.10

Buy

$7.15

arrow-down$-0.46 (-6.23%)

Prices updated at 28 May 2025, 09:49 EDT
| Prices minimum 15 mins delay
|
Prices in USD

Novavax Inc is a clinical-stage vaccine company. It is engaged in the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants.
Sector
Healthcare
Industry
Biotechnology
Chairman
Ms. Margaret G. McGlynn
CEO
Mr. John C. Jacobs
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
1,992
Head office
700 Quince Orchard Road
Gaithersburg
United States
20878
mobile
+1 240 268-2000
letter
ir@novavax.com

Key personnel

Salary
Ms. Margaret G. McGlynn
Chairman of the Board
0.08m
Mr. John J. Trizzino
Co-President and Chief Operating Officer
0.58m
Mr. Charles W. Newton
Independent Director
-
Dr. John W. Shiver, PhD
Independent Director
-
Dr. Gregg H. Alton, J.D.
Independent Director
0.07m
Mr. Richard J. Rodgers
Independent Director
0.09m
Mr. David M. Mott
Independent Director
0.08m
Mr. Mark J. Casey
Executive Vice President, Chief Legal Officer and Corporate Secretary
0.56m
Dr. Richard H. Douglas, PhD
Independent Director
0.08m
Ms. Rachel K. King
Independent Director
0.07m
Mr. John C. Jacobs
Director, President and Chief Executive Officer
0.75m
Mr. James P. Kelly
Executive Vice President, Chief Financial Officer, Treasurer and Principal Accounting Officer
0.55m
Ms. Elaine O'Hara
Executive Vice President and Chief Strategy Officer
0.54m
Dr. Ruxandra Draghia-Akli
Executive Vice President and Head of Research and Development
-

Top 5 shareholders

No. of shares
Vanguard Group Inc15,674,378
Vanguard Group Inc. ( Junked)15,430,034
BlackRock Inc12,967,029
Shah Capital Management11,131,846
State Street Corp7,039,158

Director dealings

Action
31 Dec 2024-
24 Dec 2024-
13 Dec 2024-
11 Dec 2024-
11 Dec 2024-
11 Dec 2024-
11 Nov 2024-
11 Nov 2024-
29 Oct 2024-
29 Oct 2024-
19 Aug 2024-
19 Aug 2024-
19 Aug 2024-
21 Jun 2024-
18 Jun 2024-
18 Jun 2024-
17 Jun 2024-
17 Jun 2024-
17 Jun 2024-
17 Jun 2024-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.